Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Nucala Granted Priority Review For Treatment of Hypereosinophilic Syndrome
    PhotoLizM / Pixabay

    Nucala Granted Priority Review For Treatment of Hypereosinophilic Syndrome

      According to a drug filing and press release from Pharmaceutical Business Review, the FDA granted a priority review to GlaxoSmithKline for their humanized monoclonal antibody therapy, Nucala (mepolizumab). Currently,…

    Continue Reading Nucala Granted Priority Review For Treatment of Hypereosinophilic Syndrome
    The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis
    Elizabeth M. Dugan, Adam M. Huber, Frederick W. Miller, Lisa G. Rider / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

    The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis

      This year, because of COVID-19, many healthcare-related events and symposiums have been moved online. However, that doesn't mean that the insights are any less helpful! In the virtual ACR…

    Continue Reading The Importance of Cancer Screenings in Patients with Scleroderma, Dermatomyositis
    TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
    mohamed_hassan / Pixabay

    TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

    According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

    Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
    Is There Too Much Variability in Hyperkalemia Management?
    Photo by Robina Weermeijer on Unsplash

    Is There Too Much Variability in Hyperkalemia Management?

      The virtually-held National Kidney Foundation 2020 Spring Clinical Meetings explored various topics relating to nephrological conditions, treatment, and patient outcomes. One presentation, spearheaded by Dr. Adam Weinstein, MD, and…

    Continue Reading Is There Too Much Variability in Hyperkalemia Management?
    Scientists Explore the Epigenetic Causes of PAH
    Photo by Robina Weermeijer on Unsplash

    Scientists Explore the Epigenetic Causes of PAH

      Recently, researchers from European Molecular Biology Laboratory (EMBL) looked to understand the cause of pulmonary arterial hypertension (PAH). They collaborated with Stanford University through the Life Sciences Alliance. Because…

    Continue Reading Scientists Explore the Epigenetic Causes of PAH